PhRMA Letter to HRSA and HHS Regarding Duplicate Discounting in 340B
October 11, 2024
PhRMA submitted a letter to the Health Resources and Services Administration (HRSA) and U.S. Department of Health and Human Services (HHS) expressing serious concerns regarding HRSA’s recent public statements about use of a rebate option to offer statutory 340B ceiling prices to covered entities.
